Advertisement

NAFLD/NASH Medications

The NAFLD/NASH medications' page includes experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

*generic or biosimilar available

E experimental


DRUG cenicriviroc
GENERIC NAME cenicriviroc
COMPANY Allergan
DRUG cilofexor
GENERIC NAME N/A
COMPANY Gilead Sciences
DRUG elafibranor
GENERIC NAME elafibranor
COMPANY Genfit
DRUG emricasan
GENERIC NAME emricasan
COMPANY Conatus
DRUG firsocostat
GENERIC NAME N/A
COMPANY Gilead Sciences
DRUG Ocaliva
GENERIC NAME obeticholic acid
COMPANY Intercept Pharmaceuticals
DRUG pegbelfermin
GENERIC NAME pegbelfermin
COMPANY Bristol-Myers Squibb
DRUG selonsertib
GENERIC NAME selonsertib
COMPANY Gilead Sciences
DRUG tropifexor
GENERIC NAME tropifexor
COMPANY Novartis

Last Reviewed: February 4, 2019


Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.